Showing results (61-70 of 605) with videos related to
Sort By:
Pageof 61
European Journal of Clinical Investigation|October 1, 1988
Monocytic production and plasma bioactivities of interleukin-1 and tumour necrosis factor in human cancerL L Moldawer, C Drott, K LundholmThe Journal of Clinical Endocrinology and Metabolism|April 1, 1995
Interleukin-1 receptor blockade does not affect endotoxin-induced changes in plasma thyroid hormone and thyrotropin concentrations in manT van der Poll, K J Van Zee, E Endert, et al.Journal of the American College of Surgeons|February 1, 1994
Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patientsM A Rogy, S M Coyle, H S Oldenburg, et al.The Journal of Surgical Research|April 1, 1989
Hepatocellular membrane function during chronic burn injuryJ P Minei, Y Fong, M A Marano, et al.Critical Care Medicine|May 12, 2000
Cytokine signaling--regulation of the immune response in normal and critically ill statesA Oberholzer, C Oberholzer, L L MoldawerClinical Physiology (Oxford, England)|August 1, 1987
Interleukin 1, tumour necrosis factor-alpha (cachectin) and the pathogenesis of cancer cachexiaL L Moldawer, M Georgieff, K LundholmShock (Augusta, Ga.)|August 18, 2001
Sepsis syndromes: understanding the role of innate and acquired immunityA Oberholzer, C Oberholzer, L L MoldawerAnnals of Surgery|July 1, 1994
Anti-endotoxin therapy in primate bacteremia with HA-1A and BPIM A Rogy, L L Moldawer, H S Oldenburg, et al.JPEN. Journal of Parenteral and Enteral Nutrition|July 1, 1990
Harry M. Vars award. Glutamine or fiber supplementation of a defined formula diet: impact on bacterial translocation, tissue composition, and response to endotoxinA E Barber, W G Jones, J P Minei, et al.The Journal of Experimental Medicine|November 1, 1989
Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremiaY Fong, K J Tracey, L L Moldawer, et al.Pageof 61